Skip to content

CASSIPHARMA: what changed

BE 0477.736.777NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€8,177
2024 · -€15,497+€23,675
Equity
€217,796
2024 · €217,019+€777
Cash
€294,389
2024 · €285,858+€8,531
Balance sheet total
€548,988
2024 · €555,967-€6,979

Largest movements

2024 to 2025
Assets
  • Stocks and contracts -€11,459

    down €11,459 (-8.0%), from €143,378 to €131,919

  • Cash +€8,531

    up €8,531 (+3.0%), from €285,858 to €294,389

    mainly Tax, wage and social debts (+€13,836) and Stocks and contracts (+€11,459)

Equity and liabilities
  • Trade debts -€15,164

    down €15,164 (-14.7%), from €103,344 to €88,180

  • Tax, wage and social debts +€13,836

    up €13,836 (+137%), from €10,065 to €23,902

    of which Remuneration and social security: +€7,835

  • Other debts -€6,545

    down €6,545 (-2.9%), from €225,445 to €218,900

Income statement
  • Gross operating margin +€35,260

    up €35,260 (+26.6%), from €132,499 to €167,759

  • Staff costs +€12,025

    up €12,025 (+8.1%), from €148,418 to €160,443

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€15,497
Gross operating margin +€35,260
Staff costs -€12,025
Other operating charges +€103
Financial income +€555
Financial charges -€218
Result 2025 €8,177
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€15,931
Investment €0
Financing -€7,400
Cash 2024 €285,858
Net result for the year +€8,177
Depreciation +€456
Stocks and contracts +€11,459
Receivables within one year +€3,857
Deferred charges and accrued income -€263
Trade debts -€15,164
Tax, wage and social debts +€13,836
Other debts -€6,545
Accrued charges and deferred income +€117
Contributions, distributions and other -€7,400
Cash 2025 €294,389
brings cash intakes cash out
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €555,967 €548,988 -€6,979 -1.3%
Fixed assets 21/28 €911 €456 -€456 -50.0%
Tangible fixed assets 22/27 €911 €456 -€456 -50.0%
Furniture and vehicles 24 €911 €456 -€456 -50.0%
Current assets 29/58 €555,055 €548,532 -€6,523 -1.2%
Stocks and contracts in progress 3 €143,378 €131,919 -€11,459 -8.0%
Stocks 30/36 €143,378 €131,919 -€11,459 -8.0%
Amounts receivable within one year 40/41 €123,373 €119,515 -€3,857 -3.1%
Trade receivables 40 €123,210 €118,439 -€4,771 -3.9%
Other amounts receivable 41 €162 €1,076 +€914 +563%
Cash at bank and in hand 54/58 €285,858 €294,389 +€8,531 +3.0%
Deferred charges and accrued income 490/1 €2,447 €2,710 +€263 +10.7%
Total equity and liabilities 10/49 €555,967 €548,988 -€6,979 -1.3%
Equity 10/15 €217,019 €217,796 +€777 +0.4%
Contributions 10/11 €7,845 €7,845 = 0.0%
Reserves 13 €209,174 €209,952 +€777 +0.4%
Tax-exempt reserves 132 €22,262 €22,262 = 0.0%
Distributable reserves 133 €186,912 €187,690 +€777 +0.4%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €338,948 €331,191 -€7,756 -2.3%
Amounts payable within one year 42/48 €338,854 €330,981 -€7,873 -2.3%
Trade debts 44 €103,344 €88,180 -€15,164 -14.7%
Suppliers 440/4 €103,344 €88,180 -€15,164 -14.7%
Advances received on contracts in progress 46 €0 - =
Taxes, remuneration and social security 45 €10,065 €23,902 +€13,836 +137%
Taxes 450/3 €70 €6,071 +€6,001 +8,601%
Remuneration and social security 454/9 €9,996 €17,831 +€7,835 +78.4%
Other amounts payable 47/48 €225,445 €218,900 -€6,545 -2.9%
Accrued charges and deferred income 492/3 €94 €210 +€117 +124%
Remuneration, social security and pensions 62 €148,418 €160,443 +€12,025 +8.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €456 €456 = 0.0%
Other operating charges 640/8 €1,488 €1,386 -€103 -6.9%
Gross operating margin 9900 €132,499 €167,759 +€35,260 +26.6%
Operating profit (loss) 9901 -€17,864 €5,474 +€23,338
Financial income 75/76B €2,708 €3,263 +€555 +20.5%
Recurring financial income 75 €2,708 €3,263 +€555 +20.5%
Financial charges 65/66B €342 €560 +€218 +63.9%
Recurring financial charges 65 €342 €560 +€218 +63.9%
Profit (loss) for the period before taxes 9903 -€15,497 €8,177 +€23,675
Profit (loss) for the period 9904 -€15,497 €8,177 +€23,675
Profit (loss) for the period to be appropriated 9905 -€15,497 €8,177 +€23,675

Value

latest balance sheet 30-06-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€217,796 to €217,796

Midpoint €217,796 · adjusted equity only

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €217,796
Indication €217,796

Adjusted equity

balance sheet 30-06-2025
Equity (10/15)
€217,796
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€217,796

Capitalised earnings

net result for the year (9904)
2025
€8,177
2024
-€15,497
2023
-€71,001
2022
€51,572
excluding non-recurring income and charges
€52,822
2021
€32,796
Average result
-€26,107
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 30 June 2024 and 30 June 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 17 November 2026 via checked.be.